Sector consensus Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.31 USD | +0.15% |
|
+3.46% | -0.16% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$189.27 | +2.69% | 15 | ||||||
| CHF 679.14 | +25.03% | 22 | ||||||
| US$250 | +10.69% | 20 | ||||||
| US$401.52 | +24.35% | 25 | ||||||
| ₩223,458.07 | +21.91% | 22 | ||||||
| US$538.58 | -1.74% | 12 | ||||||
| US$81.15 | +1.9% | 20 | ||||||
| US$206.19 | +10.93% | 16 | ||||||
| US$91.42 | +19.25% | 12 | ||||||
| US$85.47 | +4.64% | 23 | ||||||
| US$222.12 | +25.78% | 15 | ||||||
| €64.44 | +9.56% | 14 | ||||||
| US$50.79 | +8.03% | 14 | ||||||
| US$69.17 | +12.14% | 12 | ||||||
| €93.29 | -1.07% | 4 | ||||||
| CN¥37.01 | +26.71% | 12 | ||||||
| US$342.13 | +37.96% | 15 | ||||||
| Average | 13,344.69 | +14.04% | 16 | ||||||
| Weighted average by Cap. | 20,852.52 | +15.62% | 18 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition